Pankaj Chaturvedi

Specialty: Oncology - Tobacco-linked cancers

Location: Global

Tier: ELITE

H-Index: 110

Years Active: 0

Hospital Affiliations

• Tata Memorial - Faculty

Key Publications

1. "Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019." - JAMA Oncol (2022)
2. "Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer." - N Engl J Med (2015)
3. "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study." - JAMA Oncol (2019)
4. "Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation." - J Clin Oncol (2023)
5. "Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis." - Lancet Oncol (2024)

Knowledge Graph Relationships

Pankaj Chaturvedi is a Oncology - Tobacco-linked cancers specialist affiliated with Tata Memorial. Authored 5 scholarly articles.